ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$4.25 USD
+0.09 (2.16%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.26 +0.01 (0.24%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | -17.65% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.86 |
Next Year | -0.74 |
EPS (TTM) | -0.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.37M | 9.22M | 14.62M | 121.85M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 5.03M | 10.03M | 16.14M | 130.10M |
Low Estimate | 3.70M | 8.40M | 13.10M | 113.60M |
Year ago Sales | 0.08M | 0.14M | 0.62M | 14.62M |
Year over Year Growth Est. | 5,356.25% | 6,482.14% | 2,250.52% | 733.45% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.17 | -0.86 | -0.74 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.17 | -0.17 | -0.73 | -0.60 |
Low Estimate | -0.18 | -0.17 | -0.99 | -0.88 |
Year ago EPS | -0.19 | -0.19 | -0.99 | -0.86 |
Year over Year Growth Est. | 5.26% | 10.53% | 13.13% | 13.95% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 1 | 2 | 2 |
Down Last 30 Days | 1 | 1 | 2 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.17 | -0.86 | -0.74 |
7 Days Ago | -0.16 | -0.15 | -0.75 | -0.52 |
30 Days Ago | -0.16 | -0.15 | -0.75 | -0.52 |
60 Days Ago | -0.16 | -0.15 | -0.75 | -0.52 |
90 Days Ago | -0.16 | -0.15 | -0.75 | -0.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.17 | -0.86 | -0.74 |
Zacks Consensus Estimate | -0.18 | -0.17 | -0.86 | -0.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.20 | -0.19 | -0.19 | NA |
Estimate | -0.17 | -0.16 | -0.18 | -0.27 | NA |
Difference | -0.03 | -0.04 | -0.01 | 0.08 | 0.00 |
Surprise | -17.65% | -25.00% | -5.56% | 29.63% | -4.65% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more